![Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphoma - Lazzarino - 1998 - Cancer - Wiley Online Library Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphoma - Lazzarino - 1998 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/bb9bb199-b653-47b7-8993-12e910629806/mfig001.jpg)
Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphoma - Lazzarino - 1998 - Cancer - Wiley Online Library
![Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature | Journal of Ovarian Research | Full Text Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature | Journal of Ovarian Research | Full Text](https://media.springernature.com/w200/springer-static/cover/journal/13048.jpg)
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature | Journal of Ovarian Research | Full Text
![Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer](https://pub.mdpi-res.com/cancers/cancers-13-04224/article_deploy/html/images/cancers-13-04224-g001-550.jpg?1629630402)
Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
![Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy - ScienceDirect Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825820310738-gr1.jpg)
Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy - ScienceDirect
![Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity](https://pub.mdpi-res.com/diagnostics/diagnostics-12-02985/article_deploy/html/images/diagnostics-12-02985-g001.png?1669713043)
Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity
![Extra-ordinary High Cancer antigen 125 (CA-125) level in a 41 year-old patient with adenomyosis – ISGE Extra-ordinary High Cancer antigen 125 (CA-125) level in a 41 year-old patient with adenomyosis – ISGE](https://www.isge.org/wp-content/uploads/2021/10/TheTrocar-Vol2-Iss3_3_featured.jpg)
Extra-ordinary High Cancer antigen 125 (CA-125) level in a 41 year-old patient with adenomyosis – ISGE
![Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine](https://www.thelancet.com/cms/asset/362297e3-e465-4949-9cd3-f4e0a43c2525/gr2.jpg)
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer Corrigendum in /10.3892/mco.2021.2247 Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer Corrigendum in /10.3892/mco.2021.2247](https://www.spandidos-publications.com/article_images/mco/14/1/mco-14-01-02170-g00.jpg)
Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer Corrigendum in /10.3892/mco.2021.2247
![Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma - Nakata - 1998 - Cancer - Wiley Online Library Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma - Nakata - 1998 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/df3ebd58-d005-4607-a9bb-c18472ed6f9e/mfig001.jpg)
Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma - Nakata - 1998 - Cancer - Wiley Online Library
![Label-Free Electrochemical Immunosensor Based on One-Step Electrochemical Deposition of AuNP-RGO Nanocomposites for Detection of Endometriosis Marker CA 125 | ACS Applied Bio Materials Label-Free Electrochemical Immunosensor Based on One-Step Electrochemical Deposition of AuNP-RGO Nanocomposites for Detection of Endometriosis Marker CA 125 | ACS Applied Bio Materials](https://pubs.acs.org/cms/10.1021/acsabm.0c00821/asset/images/medium/mt0c00821_0009.gif)
Label-Free Electrochemical Immunosensor Based on One-Step Electrochemical Deposition of AuNP-RGO Nanocomposites for Detection of Endometriosis Marker CA 125 | ACS Applied Bio Materials
![Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis](https://www.frontiersin.org/files/MyHome%20Article%20Library/692083/692083_Thumb_400.jpg)